H.R. 4507 118th Congress
Transparency in Coverage Act
- Health
- Sponsor: Rep. Good, Bob [R-VA-5]
- Congress.gov ↗
Latest action, Dec 19, 2024: Placed on the Union Calendar, Calendar No. 767.
How the Senate voted
The Senate hasn't taken a roll call on this bill in the Congresses covered.
2 cosponsors
Sponsored by Rep. Good, Bob [R-VA-5] (Republican). Cosponsors by party, House members included:
- Democrats
- Republicans
- Independents
Cosponsors
1 D · 1 R
Referred to: House: Education and Workforce Committee; House: Energy and Commerce Committee; House: Ways and Means Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
7 reports
6 reports
6 reports
6 reports
6 reports
NAVITUS
FAEGRE DRINKER BIDDLE & REATH LLP
6 reports
PRIME THERAPEUTICS
STUMPTOWN STRATEGIES
6 reports
SIDECAR HEALTH, INC
THE SMITH-FREE GROUP, LLC
6 reports
5 reports
4 reports
ALNYLAM PHARMACEUTICALS
THE MCMANUS GROUP
3 reports
AMGEN
THE MCMANUS GROUP
3 reports
CIGNA CORPORATION
INVARIANT LLC
3 reports
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC.
THE MCMANUS GROUP
3 reports
The top 25 of 44 clients, by reports
| Client | Lobbying firm | Reports | Reports totaling | From | To | Senate |
|---|---|---|---|---|---|---|
| NATIONAL MULTIPLE SCLEROSIS SOCIETY | 7 | $469K | Q4 2023 | Q3 2024 | yes | |
| AMGEN INC | 6 | $18.1M | Q4 2023 | Q3 2024 | yes | |
| ARTHRITIS FOUNDATION | 6 | $575K | Q4 2023 | Q3 2024 | yes | |
| CALIFORNIA HOSPITAL ASSOCIATION | 6 | $2.3M | Q4 2023 | Q3 2024 | yes | |
| NATIONWIDE CHILDREN'S HOSPITAL INC | 6 | $325K | Q4 2023 | Q3 2024 | yes | |
| NAVITUS | FAEGRE DRINKER BIDDLE & REATH LLP | 6 | $100K | Q4 2023 | Q3 2024 | yes |
| PRIME THERAPEUTICS | STUMPTOWN STRATEGIES | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| SIDECAR HEALTH, INC | THE SMITH-FREE GROUP, LLC | 6 | $0 | Q4 2023 | Q3 2024 | yes |
| THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) | 6 | $11.8M | Q4 2023 | Q3 2024 | yes | |
| CAMBIA HEALTH SOLUTIONS | 5 | $3.2M | Q4 2023 | Q3 2024 | yes | |
| SIDECAR HEALTH, INC | 4 | $880K | Q4 2023 | Q1 2024 | yes | |
| ALNYLAM PHARMACEUTICALS | THE MCMANUS GROUP | 3 | $50K | Q4 2023 | Q3 2023 | yes |
| AMGEN | THE MCMANUS GROUP | 3 | $0 | Q4 2023 | Q3 2023 | yes |
| CIGNA CORPORATION | INVARIANT LLC | 3 | $270K | Q4 2023 | Q1 2024 | yes |
| DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. | THE MCMANUS GROUP | 3 | $210K | Q4 2023 | Q3 2023 | yes |
| EMD SERONO, INC. | THE MCMANUS GROUP | 3 | $0 | Q4 2023 | Q3 2023 | yes |
| GENENTECH | THE MCMANUS GROUP | 3 | $0 | Q4 2023 | Q3 2023 | yes |
| INCLUDED HEALTH | 3 | $90K | Q4 2023 | Q3 2023 | yes | |
| LARGE UROLOGY GROUP PRACTICE ASSOCIATION | THE MCMANUS GROUP | 3 | $270K | Q4 2023 | Q3 2023 | yes |
| PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | 3 | $14.1M | Q4 2023 | Q1 2024 | yes | |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | THE MCMANUS GROUP | 3 | $0 | Q4 2023 | Q3 2023 | yes |
| SIDECAR HEALTH | TODD STRATEGY GROUP | 3 | $0 | Q4 2023 | Q2 2024 | yes |
| ALKERMES, INC. | THE MCMANUS GROUP | 2 | $0 | Q2 2023 | Q3 2023 | yes |
| AMERICAN MEDICAL ASSOCIATION | 2 | $9.2M | Q4 2023 | Q3 2023 | yes | |
| AMERICANS FOR PROSPERITY | 2 | $740K | Q3 2023 | Q3 2024 | yes |